Leaman John Harold - Insider Non-Derivative Transactions at Traws Pharma, Inc. (TRAW) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 12, 2025, Leaman John Harold's relationship to Traws Pharma, Inc. (TRAW) is Director, and currently has 4,058 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRAW insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Leaman John Harold - Insider Non-Derivative Transactions of TRAW Common Stock

Leaman John Harold - Insider Non-Derivative Transactions at TRAW

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	Acquisition -- (Common Stock)	4058	0	4058